ID

39448

Beschrijving

Pilot Study of Vitamin D Supplementation in Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01388855

Link

https://clinicaltrials.gov/show/NCT01388855

Trefwoorden

Versies (1)
  1. 11-01-20 11-01-20 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

11 januari 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Heart Failure NCT01388855

Engels

Eligibility Heart Failure NCT01388855

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
65 years of age or older
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
new york heart association functional class ii or iii symptoms
Beschrijving

Symptoms New York Heart Association Classification

Datatype

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C1275491
ability to communicate in english or through a translator
Beschrijving

Able to communicate English Language | Translator

Datatype

boolean

Alias
UMLS CUI [1,1]
C2364293
UMLS CUI [1,2]
C0376245
UMLS CUI [2]
C0040713
competent to sign the informed consent
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
co-morbidity that would negatively impact quality of life (e.g. severe arthritis, or fibromyalgia)
Beschrijving

Comorbidity Impairing Quality of life | Arthritis Severe | Fibromyalgia

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0221099
UMLS CUI [1,3]
C0034380
UMLS CUI [2,1]
C0003864
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0016053
co-morbidity that would negatively impact vitamin d metabolism (glomerular filtration rate-15-29%, significant liver dysfunction
Beschrijving

Comorbidity Impairing Vitamin D metabolism | Glomerular Filtration Rate | Liver Dysfunction

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0221099
UMLS CUI [1,3]
C1159433
UMLS CUI [2]
C0017654
UMLS CUI [3]
C0086565
on a pharmaceutical agent that could lower vitamin d levels (e.g. glucocorticoids, anticonvulsants)
Beschrijving

Pharmaceutical Preparation Lowering Serum vitamin D level | Glucocorticoids | Anticonvulsants

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C2003888
UMLS CUI [1,3]
C0428586
UMLS CUI [2]
C0017710
UMLS CUI [3]
C0003286
taking >600 iu vitamin d (cholecalciferol or ergocalciferol) daily
Beschrijving

Intake Vitamin D IU per day | Cholecalciferol | Ergocalciferol

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512806
UMLS CUI [1,2]
C0042866
UMLS CUI [1,3]
C0439465
UMLS CUI [2]
C0008318
UMLS CUI [3]
C0014695
moderate or severe cognitive impairment
Beschrijving

Moderate cognitive impairment | Severe cognitive impairment

Datatype

boolean

Alias
UMLS CUI [1]
C3839816
UMLS CUI [2]
C3554639
contraindication to vitamin d supplementation: history of hypercalcemia or conditions that increase the risk of hypercalcemia (sarcoidosis, tuberculosis or lymphoma)
Beschrijving

Medical contraindication Vitamin D supplementation | Hypercalcemia | Condition At risk Hypercalcemia | Sarcoidosis | Tuberculosis | Lymphoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C4524013
UMLS CUI [2]
C0020437
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C1444641
UMLS CUI [3,3]
C0020437
UMLS CUI [4]
C0036202
UMLS CUI [5]
C0041296
UMLS CUI [6]
C0024299
wheelchair bound (ambulation is a component of the qol questionnaire
Beschrijving

WHEELCHAIR CONFINEMENT

Datatype

boolean

Alias
UMLS CUI [1]
C0241735
Terug naar het begin van de pagina

Similar models

Eligibility Heart Failure NCT01388855

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
65 years of age or older
boolean
C0001779 (UMLS CUI [1])
Symptoms New York Heart Association Classification
Item
new york heart association functional class ii or iii symptoms
boolean
C1457887 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Able to communicate English Language | Translator
Item
ability to communicate in english or through a translator
boolean
C2364293 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0040713 (UMLS CUI [2])
Informed Consent
Item
competent to sign the informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Comorbidity Impairing Quality of life | Arthritis Severe | Fibromyalgia
Item
co-morbidity that would negatively impact quality of life (e.g. severe arthritis, or fibromyalgia)
boolean
C0009488 (UMLS CUI [1,1])
C0221099 (UMLS CUI [1,2])
C0034380 (UMLS CUI [1,3])
C0003864 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0016053 (UMLS CUI [3])
Comorbidity Impairing Vitamin D metabolism | Glomerular Filtration Rate | Liver Dysfunction
Item
co-morbidity that would negatively impact vitamin d metabolism (glomerular filtration rate-15-29%, significant liver dysfunction
boolean
C0009488 (UMLS CUI [1,1])
C0221099 (UMLS CUI [1,2])
C1159433 (UMLS CUI [1,3])
C0017654 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
Pharmaceutical Preparation Lowering Serum vitamin D level | Glucocorticoids | Anticonvulsants
Item
on a pharmaceutical agent that could lower vitamin d levels (e.g. glucocorticoids, anticonvulsants)
boolean
C0013227 (UMLS CUI [1,1])
C2003888 (UMLS CUI [1,2])
C0428586 (UMLS CUI [1,3])
C0017710 (UMLS CUI [2])
C0003286 (UMLS CUI [3])
Intake Vitamin D IU per day | Cholecalciferol | Ergocalciferol
Item
taking >600 iu vitamin d (cholecalciferol or ergocalciferol) daily
boolean
C1512806 (UMLS CUI [1,1])
C0042866 (UMLS CUI [1,2])
C0439465 (UMLS CUI [1,3])
C0008318 (UMLS CUI [2])
C0014695 (UMLS CUI [3])
Moderate cognitive impairment | Severe cognitive impairment
Item
moderate or severe cognitive impairment
boolean
C3839816 (UMLS CUI [1])
C3554639 (UMLS CUI [2])
Medical contraindication Vitamin D supplementation | Hypercalcemia | Condition At risk Hypercalcemia | Sarcoidosis | Tuberculosis | Lymphoma
Item
contraindication to vitamin d supplementation: history of hypercalcemia or conditions that increase the risk of hypercalcemia (sarcoidosis, tuberculosis or lymphoma)
boolean
C1301624 (UMLS CUI [1,1])
C4524013 (UMLS CUI [1,2])
C0020437 (UMLS CUI [2])
C0348080 (UMLS CUI [3,1])
C1444641 (UMLS CUI [3,2])
C0020437 (UMLS CUI [3,3])
C0036202 (UMLS CUI [4])
C0041296 (UMLS CUI [5])
C0024299 (UMLS CUI [6])
WHEELCHAIR CONFINEMENT
Item
wheelchair bound (ambulation is a component of the qol questionnaire
boolean
C0241735 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial